1. Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients
- Author
-
Carlo Lombardi, Elena Roca, Barbara Bigni, Bruno Bertozzi, Camillo Ferrandina, Alberto Franzin, Oscar Vivaldi, Marcello Cottini, Andrea D'Alessio, Paolo Del Poggio, Gian Marco Conte, and Alvise Berti
- Subjects
COVID-19 ,SARS-CoV-2 ,Coronavirus ,Lymphocytes ,Platelets ,CRP ,Specialties of internal medicine ,RC581-951 - Abstract
Early prediction of COVID-19 in-hospital mortality relies usually on patients’ preexisting comorbidities and is rarely reproducible in independent cohorts. We wanted to compare the role of routinely measured biomarkers of immunity, inflammation, and cellular damage with preexisting comorbidities in eight different machine-learning models to predict mortality, and evaluate their performance in an independent population. We recruited and followed-up consecutive adult patients with SARS-Cov-2 infection in two different Italian hospitals. We predicted 60-day mortality in one cohort (development dataset, n = 299 patients, of which 80% was allocated to the development dataset and 20% to the training set) and retested the models in the second cohort (external validation dataset, n = 402).Demographic, clinical, and laboratory features at admission, treatments and disease outcomes were significantly different between the two cohorts. Notably, significant differences were observed for %lymphocytes (p
- Published
- 2021
- Full Text
- View/download PDF